Please login to the form below
Lexicon
This page shows the latest Lexicon news and features for those working in and with pharma, biotech and healthcare.
FDA starts review of Sanofi’s oral type 1 diabetes drug
According to Lexicon, sotagliflozin is also being tested in type 2 diabetes with phase III results due in 2019. ... Lexicon exercised an option to co-promote the drug in the US for the treatment of type 1 diabetes last year.
Latest news
-
Ipsen searches for new CEO after splitting top roles
Ipsen licenses the drug from Lexicon Pharmaceuticals and has rights outside the US and Japan.
-
Sanofi and Lexicon collaborate on new medication for diabetes
Sanofi and Lexicon collaborate on new medication for diabetes. Plan to develop new investigational drugsotagliflozin. ... Pascale Witz, executive VP at Sanofi, said: “ This agreement with Lexicon reinforces our commitment to helping people living with
-
Jon Linscott: If I could change one thing...
While integration, engagement and digital have been exciting additions to the marketer's lexicon we must not forget the language of our customers - which is value, choice and patient-centred.
-
Lexicon announces IBS trial results
Lexicon announces IBS trial results. Lexicon Pharmaceuticals’ TPH inhibitor LX1031 has been shown in a phase II trial to be well tolerated and provide clinical benefit to patients with irritable bowel ... doses. Lexicon now intends to advance LX1033
-
Speaking of value
Value demonstration should be based on a consistent lexicon for communicating the performance of medicines.
More from news
Approximately 1 fully matching, plus 10 partially matching documents found.
Latest Intelligence
-
Communication is the key to unlocking the potential of immuno-oncology
Marje Isabelle, Founder and CEO, Fertile Matters. This means working with others to define a new lexicon for cancer care; helping healthcare professionals stay on top of the deluge of new
-
Six degrees of participation
Similarly, social listening is a great way of understanding the patient lexicon.
-
Asthma: beyond the blue and the brown
Indeed, it challenges the validity of the term ‘asthma’in the modern day medical lexicon at all.
-
Deal Watch November 2016
Strategic alliance, options. 122.7 per. BMS/ Lexicon Pharmaceuticals. BMS-986176 for neutopathic pain (pc) plus other small molecules that act on same target.
-
Deal Watch November 2015
Under the agreement Lexicon receives an upfront payment of $300m with a further $1.4bn in development, regulatory and sales milestones. ... Lexicon will continue to lead the development programme and has retained commercial rights to type 1 diabetes in
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest appointments
-
Linda Law joins Advicenne as US VP, clinical development and med affairs
Law’s career has seen her serve in various positions for pharmaceutical companies including Procter &Gamble, Lexicon Pharmaceuticals and she has consulted on evaluation and development projects with Takeda, Confluence and
-
Onconova appoints Ajay Bansal as chief financial officer
Bansal (pictured) served as chief financial officer at Complete Genomics since May 2010, having previously held the role of chief financial officer and executive VP of business development at Lexicon Therapeutics. ... In addition to his prior roles at
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Mastering the precision medicine opportunity
While some might say that this change in lexicon is merely a progression in language, I would argue there are differences in the two approaches to identifying and treating patients.
-
Framing, provocation, and truth
It seems to be a word creeping steadily into the promotional lexicon of marketing research.
-
The Seven Cs Of Cross-Functional Brand Planning
The company needs a common and consistent way of planning. Thinking about the plan, the process, how we go about it, the tools and lexicon.
-
Social Media and Health: the Cure or the Disease?
He is also changing the Facebook lexicon, swapping 'community' for 'connection' as the ultimate good.
-
Social Media and Health: the Cure or the Disease?
He is also changing the Facebook lexicon, swapping 'community' for 'connection' as the ultimate good.
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
Featured jobs
-
Sudler London - Account Director
-
Competitive
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
Account Manager
-
Negotiable
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
-
Associate Scientific Director
-
Salary TBC
-
Senior Medical Writer
-
Salary is DOE
- Sudler London - Senior Medical Writer
-
Competitive
-
Systematic Review Lead- London
-
Negotiable
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Senior Medical Writer, MedComms Agency
-
Salary TBC
Subscribe to our email news alerts
- Tox trouble stalls Sosei/Allergan Alzheimer’s drug
- London cancer hub launched by Cancer Research UK
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Making a Difference - The Future of Pharma
- AZ prepares to file COPD triple, taking on rival GSK
- Controversy grows around GP at Hand service after minister’s endorsement
PMHub
Page & Page
Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
